by moses@docmode.com | Apr 9, 2021 | Blog
Background According to an estimate, there are more than 500 million cases of type 2 diabetes across the world, and it is only going to grow. However, the pharma brands are seen to be pushing their products through medical professionals, and not seen as taking...
by moses@docmode.com | Apr 9, 2021 | Blog
Background New York has the most number of people infected with Hepatitis C in the US. Vertex Pharmaceuticals launched its drug Incivek, approved by US and European regulators, in 2011, making it one of the fastest drug launches ever. That being said, there is a twist...
by moses@docmode.com | Apr 9, 2021 | Blog
Background When Eli Lilly got the approval for Cymbalta, an anti-depressant, after a struggle of 13 years, it had a very short window to enter the market and make its presence felt. Also, the patent for Prozac, Lilly’s big-ticket player in the field of...
by moses@docmode.com | Apr 1, 2021 | Blog
Background Most of the treatments available for Multiple Sclerosis (MS) were injection-based. Oral medication for MS was unheard of when Novartis launched Gilenya in a very crowded space for MS drugs. It wasn’t easy to break the status quo of an existing line of...
by moses@docmode.com | Apr 1, 2021 | Blog
Background Toenail fungus infection or onychomycosis is a condition with symptoms like white or yellow nail discoloration, thickening of the nail, and separation of the nail from the nail bed. It is not a condition one would actively seek out medical treatment for, at...
